Oncolytic Viruses: Turning Pathogens into Anticancer Agents

Nino Chiocca, MD, PhD
Neurosurgeon-in-Chief and Chairman, Neurosurgery, BWH; Harvey W. Cushing Professor of Neurosurgery, HMS

A pioneer in biologic treatments of central nervous system disorders, Dr. Chiocca will discuss his latest efforts where he uses oncolytic viruses to treat solid tumors. He has completed a Phase 1 trial with a first generation oncolytic HSV to treat glioblastoma and is now working on IND-enabling studies for second-generation therapeutic. Beyond glioblastoma, this technology is applicable to pancreatic cancer and many other solid tumors.

свернуть